At the EHRA 2019 congress in Lisbon, Professor Robert Storey (Professor of Cardiology, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK) joins us to discuss the latest research from the AUGUSTUS study and the challenges faced by patients with atrial fibrillation and acute coronary syndrome.
Filmed at EHRA 2019, Lisbon.
Speaker’s Disclosures: Dr Robert Storey has received consultancy fees, honoraria and/or research grants from AstraZeneca, Bayer, Bristol Myers, Haemonetics, Idorsia, Novartis, Squibb/Pfizer, PlaqueTec and Thromboserin.
1. Please explain the challenges of managing antithrombotic therapy in patients with atrial fibrillation who have concomitant acute coronary syndrome or are undergoing percutaneous coronary intervention. (0:14)
2. What is the potential role of non-vitamin K antagonist oral anticoagulants (NOACs) in managing stroke risk in these patients? (1:31)
3. Are the AUGUSTUS findings consistent with other evidence examining the role of NOACs in managing stroke risk in patients with atrial fibrillation and acute coronary syndrome? (0:14)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Share this Video
Related Videos In Atrial Fibrillation
Anthony Tang, ACC 2021: Findings from the RAFT-AF Trial
It was a great pleasure to meet with Anthony Tang to discuss the RAFT-AF trial results investigating the safety and efficacy of catheter ablation-based rhythm control compared with rate control for the treatment of patients with atrial fibrillation and heart failure, presented at ACC 2021. Abstract Title: A Randomized Ablation-based atrial Fibrillation rhythm control versus […]
Michiel Rienstra and Bao-Oanh Nguyen, EHRA 2021 – Long-term Outcomes of the RACE 3 Trial
Professor Michiel Rienstra and Dr Bao-Oanh Nguyen (University Medical Center Groningen, Groningen, The Netherlands) gave us an overview of the RACE-3 study (NCT00877643) from the European Heart Rhythm Association (EHRA) Virtual Meeting 2021. Questions: What is the rationale for targeted therapy of underlying conditions in patients with persistent atrial fibrillation (AF) and mild to moderate […]
Faizel Osman, A-A Heart Rhythm Updates 2021: 2020 ESC AF Guidelines
We spoke to Professor Faizel Osman (Consultant Cardiologist and Electrophysiologist, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK) who gave us an update about the recent new ESC Guidelines for Atrial Fibrillation and the upcoming Arrhythmia Alliance Heart Rhythm Updates 2021. Questions What are the most important new recommendations in the 2020 ESC atrial […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!